JB Chemicals & Pharmaceuticals has reported results for third quarter ended December 31, 2021.
The company has reported a fall of 50.83% in its net profit at Rs 74.57 crore for the quarter under review as compared to Rs 151.67 crore for the same quarter in the previous year. Total income of the company decreased by 3.35% at Rs 537.59 crore for Q3FY22 as compared Rs 556.20 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported a fall of 45.48% in its net profit at Rs 84.12 crore for the quarter under review as compared to Rs 154.28 crore for the same quarter in the previous year. However, total income of the company increased by 0.17% at Rs 605.18 crore for Q3FY22 as compared Rs 604.17 crore for the corresponding quarter previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1858.70 |
Dr. Reddys Lab | 1258.55 |
Cipla | 1559.20 |
Lupin | 2198.25 |
Zydus Lifesciences | 1004.00 |
View more.. |